Yu-ju Tseng - Publications

Neurotoxicity risk associated with cefepime versus piperacillin-tazobactam in hospitalized patients with pneumonia: a real-world cohort study.

Journal: Expert review of anti-infective therapy

Published: July 10, 2026

Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort.

Journal: Infection and drug resistance

Published: March 08, 2026

Optimal Piperacillin/Tazobactam Dosing in Adults with Low Body Weight: A Population Pharmacokinetic and Simulation-Based Study.

Journal: Drug design, development and therapy

Published: February 26, 2026

Chylous Ascites Manifesting as Vulvovaginal Chyle Leakage: A Rare Gynecologic Presentation.

Journal: Journal of minimally invasive gynecology

Published: December 31, 2025

Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: December 23, 2025

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Intravenous Vancomycin in Intracranial Hemorrhage Patients with External Ventricular Drains: Implications for Dosing and Therapeutic Drug Monitoring.

Journal: Drug design, development and therapy

Published: October 15, 2025

Navigating pharmacokinetic and pharmacodynamics challenges of β-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization.

Journal: Therapeutic advances in drug safety

Published: September 12, 2024

Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma.

Journal: Brain sciences

Published: November 09, 2022

Successful treatment of Zoon's balanitis with low-dose methotrexate in a topical agent-resistant patient.

Journal: The Australasian journal of dermatology

Published: June 19, 2022

Plasminogen Activator Inhibitor-1 Secretion by Autophagy Contributes to Melanoma Resistance to Chemotherapy through Tumor Microenvironment Modulation.

Journal: Cancers

Published: February 26, 2021

Inhibition of PAI-1 Blocks PD-L1 Endocytosis and Improves the Response of Melanoma Cells to Immune Checkpoint Blockade.

Journal: The Journal of investigative dermatology

Published: December 15, 2020

Factors to influence the accuracy of albumin adjusted free valproic acid concentration.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: May 11, 2020